Americas Tops the Sexually Transmitted Diseases Testing Market| Technavio

Technavio has published a new market research report on the global sexually transmitted diseases testing market 2018-2022 under their healthcare and life sciences library. (Graphic: Business Wire)

LONDON--()--The latest market research report by Technavio on the global sexually transmitted diseases testing market predicts a CAGR of close to 9% during the period 2018-2022.

The report segments the global sexually transmitted diseases testing market by testing devices (laboratory testing devices and POC testing devices) and by geography (the Americas, EMEA, and APAC). It provides a detailed illustration of the major factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Here are some key findings of the global sexually transmitted diseases testing market, according to Technavio healthcare and life sciences researchers:

  • Rise in STDs: a major market driver
  • The Americas dominated the global sexually transmitted diseases testing market with close to 41% share in 2017
  • Abbott, bioMerieux, Bio-Rad Laboratories, and F. Hoffmann La Roche are some of the players in the market
  • High demand for POC testing: a key market trend

Save more with Technavio. Buy 2 reports and get the third for free: View Technavio’s latest discounts and promotions

Rise in STDs: a major market driver

Rise in STDs is one of the major factors driving the global sexually transmitted diseases testing market. The increase in STDs has become a global public health challenge. STDs include more than 25-30 infectious diseases that are spread through sexual activity. A person needs to visit a health clinic or hospital for STD testing and treatment if exposed to a sexually transmitted pathogen. Common STDs include chlamydia, syphilis, gonorrhea, herpes, HPV, and HIV infections. Syphilis is a genital ulcerative disease caused by the bacterium Treponema pallidum. If not treated, Syphilis can make one vulnerable to an HIV infection.

According to a senior analyst at Technavio for research on in-vitro diagnostics, “According to the CDC, 350,062 cases of gonorrhea were reported in the US in 2014. This rate has increased by 5.1% from 2013. In 2015, approximately 3.62 billion people below 50 years were infected with herpes simplex virus. This increase in the prevalence of STDs has resulted in an increased demand for STD testing that is benefitting the global STD testing market.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Americas: largest sexually transmitted diseases testing market

In 2017, the global STD testing market was led by the Americas that accounted for a share of close to 42% because of the region's advanced healthcare infrastructure. The Americas was followed by EMEA with approximately 34% market share due to shift toward preventive and personalized healthcare, aided by efficient diagnostic procedures, in the region. In 2017, APAC accounted for around 25% market share because of an increasing prevalence of diseases such as HIV and syphilis. By 2022, the Americas will continue to lead the market due to increasing awareness about testing for STDs and the initiatives taken by governments to promote various tests.

High demand for POC testing: a key market trend

The diagnostic sector is undergoing revolutionary changes with device miniaturization, growth in testing menus, and the introduction of multi-parameter testing devices. Another substantial development in this sector is the emergence of POC testing. The miniaturization of laboratory functions onto portable systems allows testing of individual living cells and small volumes of reagent samples. Therefore, this technology is motivating hospitals and clinics to switch to POC testing because of the associated low-cost, quick test outcomes, and fast turnaround times. With the developments of sensors, microsystems, and low-cost imaging technologies, POC testing combines multiple analytical functions in self-contained portable devices to detect and diagnose diseases.

Get a sample copy of the global sexually transmitted diseases testing market report free of cost

Access Technavio’s continuously growing in-vitro diagnostics research library and find expert analysis on hundreds of markets.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The latest market research report by Technavio on the global sexually transmitted diseases testing market predicts a CAGR of nearly 9% through 2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com